Trusted Partnerships

Partnerships for Success

Ryan Lee

Samsung Biologics

Monoclonal Antibodies

Coriolis Pharma Launches U.S. Entity Alongside Innovative Drug Product Platform Service Offerings for Monoclonal Antibodies

Coriolis Pharma

Hybrid Modeling

Accelerating and Improving Bioprocess Development with Machine Learning Solutions

Michael Sokolov, Ph.D.; Alessandro Butté, Ph.D.

DataHow

Training

Biotech Training is a Challenge

April Stanley, MS MBA; Koey Keylon

Leap-In Transposase

Leveraging Innovative Transposase Technology for a Highly Reliable and Productive CMC Platform

Wheeler Bio

The PHASE Platform

How Synergistic Collaborations Between Outsourcing Partners Can Accelerate Clinical Success

Wheeler Bio

Down Stream Processing

Expediting Biologics Drug Development: Downstream Strategies to Accelerate Preclinical Development Timelines

Songyoung Kim

Samsung Biologics

Outsourced Manufacturing

A Closer Look at Small Molecule Drug Substance and Drug Product Manufacturing

April Stanley, MS MBA

IND, NDA, and BLA

Building a Regulatory Roadmap for IND, NDA, and BLA

Rebecca Lamb-Wharton, Ph.D.; Brenda Schlenk, RPh; Mamadou Diallo, PharmD

Analytical Method Development

Harnessing Biologic Development Experience in Support of CDMO Clients: Rapid, Effective and Tailored Analytical Method Development

Xuemei Han Aslain

Bispecific Antibodies

Accelerating the Development and Production of High-Quality Bispecific Antibodies

Dongyoung Park

Samsung Biologics

CDMO - Small Biotech

Cis-Targeted Immunotherapies Need Large CDMO Expertise But Also Flexibility

Julie Trulson, Ph.D.

Tech Transfer

Transparent Communication Supports Tech Transfers Of Cis-targeted Immunotherapies

Julie Trulson, Ph.D.

Biologics Formulation

Successful Formulation Development for Biologics Using a Unique Biophysical Prediction and Screening Platform

Pawel Stanczak, Ph.D.

Recombinant Antibody

Recombinant Antibody Technology is Crucial to Past and Future Success in Biopharma

Suranjana Sen, Ph.D.

Sino Biological

Glycosylation

S-Glyn™ : Optimizing N-Glycan Profiles and their Effector Functions Using a Design-of-Experiments Approach

Junyong Park

Samsung Biologics

Cell and Gene Therapy

Scaling Cell and Gene Therapy Processes from R&D to Production

Shawn Bates; Antonio Fernandez-Perez, Ph.D.

Corning Life Sciences

Cell Culture Media

Market Trends Driving the Embrace of Plant-Based Cell-Culture Media Ingredients

Chris Wiedel

Nu-Tek BioSciences

Vaccines

Delivering a Next-Generation COVID-19 Vaccine for Immunocompromised Patients and Novel Cancer Vaccines

David Dodd; Mark Newman, Ph.D.

GeoVax Inc.

Alloy Therapeutics and Wheeler Bio Announce Preferred Service Offering for Alloy Partners to Accelerate the Translation from Discovery to CMC

Wheeler Bio